飛凱材料(300398.SZ)2021年度財務預算報吿:計劃實現營收增長不低於15%、利潤總額增長不低於20%
格隆匯 3 月 17日丨飛凱材料(300398.SZ)公佈,根據公司生產經營發展計劃,參照公司近年來的經營業績增幅及現有生產能力,結合目前市場環境,按照合併報表口徑及企業會計準則相關規定,經公司董事會分析研究,公司2021年度的財務預算報吿如下:
1、收入目標:2021年計劃實現營業收入較2020年增長不低於15%。
2、利潤目標:2021年計劃實現利潤總額較2020年增長不低於20%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.